Callos Andrew bought CYTK

May 5, 2026 · Form 4 insider transaction

Callos Andrew bought 11,333 shares of Cytokinetics, Incorporated at $39.13 per share, a transaction worth $443.5K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 0 days after the transaction.